China Energy Storage Technology Development Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

China Energy Storage Technology Development şirketinin toplam hissedar öz sermayesi HK$497.5M ve toplam borcu HK$7.8M olup, bu da borç-öz sermaye oranını 1.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla HK$798.1M ve HK$300.6M dir. China Energy Storage Technology Development 'in FAVÖK'ü HK$24.9M faiz karşılama oranı -2.7 dur. Şirketin HK$293.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

1.6%

Borç/özkaynak oranı

HK$7.84m

Borç

Faiz karşılama oranı	-2.7x
Nakit	HK$293.05m
Eşitlik	HK$497.46m
Toplam yükümlülükler	HK$300.64m
Toplam varlıklar	HK$798.10m

Son finansal sağlık güncellemeleri

Is Link-Asia International MedTech Group (HKG:1143) Using Debt In A Risky Way?

Oct 29

Health Check: How Prudently Does Link-Asia International (HKG:1143) Use Debt?

Dec 16

Recent updates

Revenues Not Telling The Story For China Energy Storage Technology Development Limited (HKG:1143)

Sep 20

Subdued Growth No Barrier To China Energy Storage Technology Development Limited's (HKG:1143) Price

May 13

China Energy Storage Technology Development Limited's (HKG:1143) Popularity With Investors Is Under Threat From Overpricing

Jan 23

Unpleasant Surprises Could Be In Store For Link-Asia International MedTech Group Limited's (HKG:1143) Shares

Apr 18

Is Link-Asia International MedTech Group (HKG:1143) Using Debt In A Risky Way?

Oct 29

Health Check: How Prudently Does Link-Asia International (HKG:1143) Use Debt?

Dec 16

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 1143 'nin kısa vadeli varlıkları ( HK$743.4M ) kısa vadeli yükümlülüklerini ( HK$266.2M ) aşıyor.

Uzun Vadeli Yükümlülükler: 1143 şirketinin kısa vadeli varlıkları ( HK$743.4M ) uzun vadeli yükümlülüklerini ( HK$34.5M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 1143 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 1143 'nin borç/öz sermaye oranı son 5 yılda 7.5% seviyesinden 1.6% seviyesine düştü.

Borç Kapsamı: 1143 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: 1143 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

China Energy Storage Technology Development Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Link-Asia International MedTech Group (HKG:1143) Using Debt In A Risky Way?

Health Check: How Prudently Does Link-Asia International (HKG:1143) Use Debt?

Recent updates

Investor sentiment improves as stock rises 18%

First half 2024 earnings released: HK$0.02 loss per share (vs HK$0.03 loss in 1H 2023)

China Energy Storage Technology Development Limited Announces Appointment of Wang Qi as Executive Director

Revenues Not Telling The Story For China Energy Storage Technology Development Limited (HKG:1143)

China Energy Storage Technology Development Limited to Report First Half, 2024 Results on Aug 29, 2024

New major risk - Earnings quality

Subdued Growth No Barrier To China Energy Storage Technology Development Limited's (HKG:1143) Price

China Energy Storage Technology Development Limited has completed a Follow-on Equity Offering in the amount of HKD 17.9034 million.

China Energy Storage Technology Development Limited has filed a Follow-on Equity Offering in the amount of HKD 17.9034 million.

Full year 2023 earnings released: EPS: HK$0.031 (vs HK$0.50 loss in FY 2022)

China Energy Storage Technology Development Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

China Energy Storage Technology Development Limited's (HKG:1143) Popularity With Investors Is Under Threat From Overpricing

China Energy Storage Technology Development Limited Announces Board Appointment

New major risk - Shareholder dilution

Link-Asia International MedTech Group Limited Announces Board Changes

Link-Asia International Medtech Group Limited Announces Executive Changes

First half 2023 earnings released: HK$0.03 loss per share (vs HK$0.14 loss in 1H 2022)

Link-Asia International MedTech Group Limited to Report First Half, 2023 Results on Aug 31, 2023

Link-Asia International MedTech Group Limited Announces Resignation of Li Yinxiang as Executive Director

Link-Asia International MedTech Group Limited Announces Executive Changes

Link-Asia International MedTech Group Limited, Annual General Meeting, Jun 08, 2023

Unpleasant Surprises Could Be In Store For Link-Asia International MedTech Group Limited's (HKG:1143) Shares

Link-Asia International MedTech Group Limited has completed a Follow-on Equity Offering in the amount of HKD 96.0148 million.

Less than half of directors are independent

Less than half of directors are independent

Link-Asia International MedTech Group Limited Appoints Liu Zhiwei as Executive Director, with Effect from 1 November 2022

First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.07 loss in 1H 2021)

First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.07 loss in 1H 2021)

Link-Asia International MedTech Group Limited to Report First Half, 2022 Results on Aug 31, 2022

Link-Asia International Medtech Group Limited Announces Resignation of Duan Chuanhong as an Executive Director

Link-Asia International MedTech Group Limited, Annual General Meeting, Jun 07, 2022

Link-Asia International MedTech Group Limited, Annual General Meeting, Jun 07, 2022

Less than half of directors are independent

Link-Asia International MedTech Group Limited to Report Fiscal Year 2021 Final Results on Apr 29, 2022

Full year 2021 earnings released: HK$0.078 loss per share (vs HK$0.46 loss in FY 2020)

Link-Asia International MedTech Announces Management Changes

Is Link-Asia International MedTech Group (HKG:1143) Using Debt In A Risky Way?

Company Secretary Keying Gao has left the company

First half 2021 earnings released: HK$0.07 loss per share (vs HK$0.20 loss in 1H 2020)

Link-Asia International Medtech Group Limited Provides Earnings Guidance for the Six Months Ended 30 June 2021

Link-Asia International MedTech Group Limited has completed a Follow-on Equity Offering in the amount of HKD 23.005696 million.

Full year 2020 earnings released

Link-Asia International MedTech Group Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day high: HK$0.63

New 90-day low: HK$0.34

Link-Asia International MedTech Group Limited has completed a Follow-on Equity Offering in the amount of HKD 29.953 million.

Link-Asia International Co. Ltd. Appoints Sun Xiaohu as an Independent Non-Executive Director and A Member of Audit Committee

New 90-day high: HK$0.61

Health Check: How Prudently Does Link-Asia International (HKG:1143) Use Debt?

New 90-day high: HK$0.60

Link-Asia International Co. Ltd. Announces Executive Changes

First half earnings released

New 90-day high - HK$0.58

First half earnings released

Link-Asia International Co. Ltd. to Report First Half, 2020 Results on Aug 28, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin